S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

AtriCure, Inc.

ATRC XNAS
$26.28 -1.52 (-5.47%) ▼ 15-min delayed
Open
$27.92
High
$27.98
Low
$26.08
Volume
955.7K
Market Cap
$1.33B

About AtriCure, Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 1.4K Website →

Key Financials

Period Revenue Net Income EPS
Q1 2026 $141.25M $108.0K $0.00
FY 2025 $534.53M $-11,448,000 $-0.24
Q3 2025 $134.27M $-267,000 $-0.01
Q2 2025 $136.14M $-6,190,000 $-0.13

Related Market News

No specific coverage for ATRC yet. Check out our latest market news or earnings calendar.

Get ATRC Alerts

Stay ahead with breaking news, price alerts, and expert analysis on AtriCure, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.